Clinical Trials Logo

Mandible; Deformity clinical trials

View clinical trials related to Mandible; Deformity.

Filter by:
  • None
  • Page 1

NCT ID: NCT05602909 Recruiting - Mandible; Deformity Clinical Trials

Guided Biaxial Alveolar Distraction Device in Posterior Atrophic Mandible

Start date: June 23, 2022
Phase: N/A
Study type: Interventional

Atrophic alveolar bone presents a unique difficulty, preventing correct implant placement and affecting long-term results. There are different techniques that are recommended to restore the proper length of the posterior ridge of the mandible and thus achieve proper form and function, one of those is distraction osteogenesis. Refinements in the technique of distraction can improve the treatment outcome and decrease postoperative complications.

NCT ID: NCT04910074 Suspended - Nerve Injury Clinical Trials

LLLT Effects on Inferior Alveolar Nerve (IAN) Recovery Post-orthognathic Surgery

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Low-level laser therapy (LLLT) is a well-studied technique that has been shown to improve recovery time and reduce pain and swelling in patients undergoing surgery, including orthognathic surgery, and has no known negative effects. This study will use two groups with patients randomly assigned to either the study group, receiving LLLT, or one receiving a placebo treatment, after they have lower jaw surgery. Measurements will be taken at 24 hours, 1 week, 2 week, 3 week, 4 week, 5 week, and 6 week post-op exams to check pain, swelling and nerve function, and the two groups will be compared to see if the LLLT group has any difference

NCT ID: NCT03678467 Recruiting - Mandibular Injuries Clinical Trials

Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction

EB-CMF
Start date: March 31, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

EpiBone-Craniomaxillofacial (EB-CMF) is an autologous, anatomically shaped bone graft created specifically for the patient's defect, using the patients own adipose-derived mesenchymal stem cells. This first in human trial is designed specifically to assess the safety of EB-CMF clinically. Although secondary measures of graft efficacy are being assessed, the primary focus will be on Adverse Events stemming from graft implantation.